Richard A Graham is SVP, RESEARCH & DEVELOPMENT of Theravance Biopharma, Inc.. Currently has a direct ownership of 314,915 shares of TBPH, which is worth approximately $3.02 Million. The most recent transaction as insider was on Feb 20, 2024, when has been sold 19,294 shares (Ordinary Shares) at a price of $8.92 per share, resulting in proceeds of $172,102. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 315K
0% 3M change
5.77% 12M change
Total Value Held $3.02 Million

RICHARD A GRAHAM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
SELL
Payment of exercise price or tax liability
$172,102 $8.92 p/Share
19,294 Reduced 5.77%
314,915 Ordinary Shares
Nov 20 2023
SELL
Payment of exercise price or tax liability
$130,973 $10.37 p/Share
12,630 Reduced 3.64%
334,209 Ordinary Shares
Nov 14 2023
SELL
Open market or private sale
$25,366 $10.22 p/Share
2,482 Reduced 0.71%
346,839 Ordinary Shares
Oct 30 2023
BUY
Grant, award, or other acquisition
-
15,000 Added 4.12%
349,321 Ordinary Shares
Oct 16 2023
SELL
Open market or private sale
$22,412 $9.03 p/Share
2,482 Reduced 0.74%
334,321 Ordinary Shares
Sep 14 2023
SELL
Open market or private sale
$24,546 $9.89 p/Share
2,482 Reduced 0.73%
336,803 Ordinary Shares
Aug 20 2023
SELL
Payment of exercise price or tax liability
$101,471 $9.7 p/Share
10,461 Reduced 2.99%
339,285 Ordinary Shares
Aug 11 2023
SELL
Open market or private sale
$23,196 $9.99 p/Share
2,322 Reduced 0.66%
349,746 Ordinary Shares
Jul 14 2023
SELL
Open market or private sale
$22,848 $9.84 p/Share
2,322 Reduced 0.66%
352,068 Ordinary Shares
Jun 14 2023
SELL
Open market or private sale
$24,822 $10.69 p/Share
2,322 Reduced 0.65%
354,390 Ordinary Shares
May 20 2023
SELL
Payment of exercise price or tax liability
$117,256 $11.21 p/Share
10,460 Reduced 2.85%
356,712 Ordinary Shares
May 15 2023
SELL
Open market or private sale
$26,145 $11.26 p/Share
2,322 Reduced 0.63%
367,172 Ordinary Shares
Apr 14 2023
SELL
Open market or private sale
$27,597 $11.88 p/Share
2,323 Reduced 0.62%
369,494 Ordinary Shares
Mar 14 2023
SELL
Open market or private sale
$23,973 $10.32 p/Share
2,323 Reduced 0.62%
371,817 Ordinary Shares
Mar 06 2023
SELL
Open market or private sale
$23,346 $10.05 p/Share
2,323 Reduced 0.62%
374,140 Ordinary Shares
Mar 01 2023
BUY
Grant, award, or other acquisition
-
75,000 Added 16.61%
376,463 Ordinary Shares
Feb 20 2023
SELL
Payment of exercise price or tax liability
$125,875 $10.44 p/Share
12,057 Reduced 3.85%
301,463 Ordinary Shares
Dec 01 2022
SELL
Open market or private sale
$22,361 $10.73 p/Share
2,084 Reduced 0.66%
313,520 Ordinary Shares
Nov 20 2022
SELL
Payment of exercise price or tax liability
$296,747 $10.85 p/Share
27,350 Reduced 7.97%
315,604 Ordinary Shares
Nov 16 2022
SELL
Payment of exercise price or tax liability
$31,359 $11.2 p/Share
2,800 Reduced 0.81%
342,954 Ordinary Shares
Aug 19 2022
SELL
Payment of exercise price or tax liability
$177,376 $9.34 p/Share
18,991 Reduced 5.21%
345,754 Ordinary Shares
Aug 16 2022
SELL
Open market or private sale
$47,637 $9.71 p/Share
4,906 Reduced 1.33%
364,745 Ordinary Shares
Aug 09 2022
SELL
Open market or private sale
$132,606 $8.79 p/Share
15,086 Reduced 3.92%
369,651 Ordinary Shares
May 20 2022
SELL
Payment of exercise price or tax liability
$34,497 $8.74 p/Share
3,947 Reduced 1.02%
384,737 Ordinary Shares
Feb 18 2022
SELL
Payment of exercise price or tax liability
$195,823 $9.61 p/Share
20,377 Reduced 4.98%
388,684 Ordinary Shares
RAG

Richard A Graham

SVP, RESEARCH & DEVELOPMENT
South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH